<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Influence of essential amino acids on muscle mass and muscle strength in patients with cerebral stroke during early rehabilitation: protocol and rationale of a randomized clinical trial (AMINO-Stroke Study)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Nadja</forename><surname>Scherbakov</surname></persName>
							<idno type="ORCID">0000-0002-5890-9888</idno>
							<affiliation key="aff0">
								<orgName type="department">Center for Stroke Research Berlin CSB</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="laboratory">German Centre for Cardiovascular Research (DZHK)</orgName>
								<address>
									<addrLine>partner site Berlin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Center for Stroke Research Berlin CSB</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="laboratory">German Centre for Cardiovascular Research (DZHK)</orgName>
								<address>
									<addrLine>partner site Berlin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nicole</forename><surname>Ebner</surname></persName>
							<idno type="ORCID">0000-0002-5890-9888</idno>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Innovative Clinical Trials</orgName>
								<orgName type="department" key="dep2">Department of Cardiology and Pneumology</orgName>
								<orgName type="institution">University MedicineGöttingen (UMG)</orgName>
								<address>
									<settlement>Göttingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anja</forename><surname>Sandek</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Innovative Clinical Trials</orgName>
								<orgName type="department" key="dep2">Department of Cardiology and Pneumology</orgName>
								<orgName type="institution">University MedicineGöttingen (UMG)</orgName>
								<address>
									<settlement>Göttingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Meisel</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Stroke Research Berlin CSB</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Center for Stroke Research Berlin CSB</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karl</forename><forename type="middle">Georg</forename><surname>Haeusler</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Stroke Research Berlin CSB</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Center for Stroke Research Berlin CSB</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephan</forename><surname>Von Haehling</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Innovative Clinical Trials</orgName>
								<orgName type="department" key="dep2">Department of Cardiology and Pneumology</orgName>
								<orgName type="institution">University MedicineGöttingen (UMG)</orgName>
								<address>
									<settlement>Göttingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefan</forename><forename type="middle">D</forename><surname>Anker</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Innovative Clinical Trials</orgName>
								<orgName type="department" key="dep2">Department of Cardiology and Pneumology</orgName>
								<orgName type="institution">University MedicineGöttingen (UMG)</orgName>
								<address>
									<settlement>Göttingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ulrich</forename><surname>Dirnagl</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Center for Stroke Research Berlin CSB</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="laboratory">German Centre for Cardiovascular Research (DZHK)</orgName>
								<address>
									<addrLine>partner site Berlin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Center for Stroke Research Berlin CSB</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="laboratory">German Centre for Cardiovascular Research (DZHK)</orgName>
								<address>
									<addrLine>partner site Berlin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Joebges</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Brandenburgklinik Bernau</orgName>
								<address>
									<settlement>Bernau</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Wolfram</forename><surname>Doehner</surname></persName>
							<email>wolfram.doehner@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Center for Stroke Research Berlin CSB</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="laboratory">German Centre for Cardiovascular Research (DZHK)</orgName>
								<address>
									<addrLine>partner site Berlin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Center for Stroke Research Berlin CSB</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="laboratory">German Centre for Cardiovascular Research (DZHK)</orgName>
								<address>
									<addrLine>partner site Berlin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Influence of essential amino acids on muscle mass and muscle strength in patients with cerebral stroke during early rehabilitation: protocol and rationale of a randomized clinical trial (AMINO-Stroke Study)</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">31BF986391BB6854FA603D7E52CF8C85</idno>
					<idno type="DOI">10.1186/s12883-016-0531-5</idno>
					<note type="submission">Received: 24 October 2015 Accepted: 14 January 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:19+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Double blinded randomized study</term>
					<term>Post-stroke rehabilitation</term>
					<term>Skeletal muscle wasting</term>
					<term>Physical performance</term>
					<term>Essential amino acids</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Patients with stroke are at a high risk for long-term handicap and disability.</s><s>In the first weeks after stroke muscle wasting is observed frequently.</s><s>Early post-stroke rehabilitation programs are directed to improve functional independence and physical performance.</s><s>Supplementation with essential amino acids (EAAs) might prevent muscle wasting and improve rehabilitation outcome by augmenting muscle mass and muscle strength.</s><s>We aim to examine this in a double blinded, randomized placebo-controlled clinical trial.</s><s>Methods: Patients with ischemic or haemorrhagic stroke will be enrolled at begin of the early post-stroke rehabilitation in a parallel group interventional trial.</s><s>Oral supplementation of EAAs or placebo will be given for 12 weeks in a double blinded manner.</s><s>Physical and functional performance will be assessed by exercise testing before supplementation of EAAs as well as at discharge from the in-patient rehabilitation, at 12 weeks and 1 year afterwards.</s><s>Discussion: This is the first randomized double-blinded placebo-controlled clinical study aiming to assess the effect of the EAAs supplementation on muscle strength, muscle function and physical performance in stroke patients during early post-stroke rehabilitation.</s><s>Supplementation of EAAs could prevent muscle mass wasting and improve functional independence after stroke.</s></p><p><s>Trial registration: The study is registered at the German registry for clinical trials as well as at World Health Organization (WHO; number DRKS00005577).</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Long-term disability and functional dependency are the main complications after stroke.</s><s>Impaired skeletal muscle innervation due to damage results in the degeneration of motor units, paresis, and immobility accompanied by skeletal muscle atrophy <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref>.</s><s>Notably, loss of muscle mass and muscle function, defined as sarcopenia, have been originally described as a phenomenon of aging <ref type="bibr" target="#b4">[5]</ref>.</s><s>However, muscle wasting observed in stroke patients is a disease-related phenomenon and the term 'stroke-related sarcopenia' has been suggested <ref type="bibr" target="#b0">[1]</ref>.</s><s>The aetiology of sarcopenia is multifactorial <ref type="bibr" target="#b5">[6]</ref>.</s><s>This is also true for stroke-depended sarcopenia.</s><s>Several pathophysiological mechanisms including metabolic imbalance, inactivity, malnutrition, and inflammation may contribute to the reduction of muscle mass after stroke <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8]</ref>.</s><s>Stroke-related muscle wasting is accompanied by body weight loss, neuro-hormonal activation, and a systemic shift towards catabolic over-activation <ref type="bibr" target="#b7">[8]</ref>.</s><s>In addition, activation of catabolic pathways in the skeletal muscle of the paretic and non-paretic limbs has been observed in experimental stroke <ref type="bibr" target="#b8">[9]</ref>.</s></p><p><s>Early rehabilitation has a great impact on the functional recovery after stroke.</s><s>A previous study showed that 80 % of the patients achieve best functional recovery within 6 weeks after stroke, and after 12.5 weeks 95 % of all stroke patients completed their functional recovery <ref type="bibr" target="#b9">[10]</ref>.</s><s>However, one year after stroke more than 30 % of the patients remained functionally dependent <ref type="bibr" target="#b10">[11]</ref>.</s></p><p><s>Skeletal muscles play a central role in post-stroke rehabilitation.</s><s>The goal of rehabilitation is to restore functional muscle capacity and to prevent long-term disability.</s><s>Therefore, prevention of muscle wasting, increasing muscle strength, reactive development of novel neuromuscular junctions, and stabilisation of the catabolic-anabolic imbalance are primary aims of poststroke rehabilitation.</s></p><p><s>Nutritional intervention may contribute to the improvement of muscle bulk and functional capacity in the early post-stroke rehabilitation.</s><s>Thus, a beneficial effect of dietary supplementation of essential amino acids (EAAs) has been shown for an improvement of skeletal muscle mass and function in the elderly <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b12">13]</ref>.</s><s>Availability of EAAs is regarded as a limiting step in the synthesis of new muscle proteins <ref type="bibr" target="#b13">[14]</ref>.</s></p><p><s>Previously it has been shown that supplementation of EAAs in the elderly was responsible for amino acidinduced stimulation of muscle protein anabolism <ref type="bibr" target="#b14">[15]</ref>.</s><s>Therefore, an individually adjusted rehabilitation program that includes physical, functional and neuropsychological training as well as dietary supplementation of the EAA might provide the best rehabilitation outcome.</s><s>Thus, in the present clinical trial the following hypotheses will be tested:</s></p><p><s>Oral uptake of EAAs restores skeletal muscle function and physical performance; Oral uptake of EAAs contributes to physical independence and enhances the effectiveness of post-stroke rehabilitation; Availability of EAAs reduces muscle wasting after stroke.</s></p><p><s>We aim to demonstrate that nutritional supplementation with biologically limited available EAAs (l-leucine, l-lysine, l-isoleucine, l-valine, l-threonine, l-cystine, lhistidin, l-phenylalanine, l-methionine, l-tyrosin, and ltryptophane), in synergy with individually adjusted physical training prevent muscle wasting after stroke and improve the effect of post-stroke early rehabilitation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study design</head><p><s>The "Influence of essential amino acids on muscle mass and muscle strength in patients with cerebral stroke during early rehabilitation (AMINO-Stroke)" study is a randomized double-blinded placebo controlled interventional clinical trial.</s><s>The study is planed as a monocentric trial within the interdisciplinary trial programme of the Center for Stroke Research Berlin (CSB) and is funded by the German Federal Ministry of Education and Research (BMBF; grant number CSB 01EO1301).</s><s>The study has been approved by the Brandenburg Ethics Committee for the recruiting site (S13(a)/2013) and is conducted in accordance with the Declaration of Helsinki.</s><s>The study is registered at the German registry for clinical trials as well as at World Health Organization (WHO; number DRKS00005577).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patient eligibility</head><p><s>Patients admitted to the rehabilitation centre Brandenburg Klinik, Bernau, Germany within 8 weeks after ischemic or haemorrhagic stroke will be screened for the eligibility.</s><s>Patients of both genders, aged 45 years or older will be informed about the study.</s><s>After obtaining of written informed consent from the patients they will be randomized 1:1 to intervention and control group by a web-based online randomization procedure provided by the Pharmacy at the Charité.</s><s>For inclusion and exclusion criteria see Table <ref type="table">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Planned clinical follow-up visits</head><p><s>In order to evaluate an effect of the EAAs on muscle function, baseline functional assessment program will be performed at admission, followed by follow-up assessment at discharge from the in-patient rehabilitation (Table <ref type="table">2</ref>).</s><s>All patients included into the study will receive 12 weeks either the EAAs (4 gram, 3 times a day) or placebo dissolved in a glass of water as a drinking solution.</s></p><p><s>Two weeks after the enrolment a study nurse visit for evaluation of compliance of the EEAs supplementation and tolerance to the compound is planned.</s><s>After discharge from the in-patient rehabilitation, two follow-up visits at 3 and at 12 months are planned.</s><s>Patients will be tested for functional performance and physical independence during a 1-day ambulatory visit.</s><s>Patients, who are unable to visit the study centre will be contacted by telephone and interviewed using a standardised questionnaire.</s><s>The study design is summarized in Fig. <ref type="figure" target="#fig_0">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Outcomes and endpoints</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Primary outcomes</head><p><s>Primary outcomes will be assessed at the 4 week followup visit.</s><s>Primary endpoints include:</s></p><p><s>1) Physical performance according to the Rivermead motor assessment (RMA) gross function scale; 2) Muscle strength in a maximum hand grip strength test.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Secondary outcomes</head><p><s>Secondary endpoints include:</s></p><p><s>1) Functional outcome assessed by Barthel Index (BI); 2) Quality of life assessed according to EuroQoL (EQ)-5D (EQ-5D) questionnaire at 3 and 12 months follow up visits; 3) Muscle function and motor capabilities assessed by pinch grip strength test, motor assessment scale, Fugl-Meyer Score functional domain), Functional ambulatory capacity and short physical performance battery test; 4) Changes of body composition assessed by bioelectrical impedance analysis (BIA); 5) Changes in insulin sensitivity; 6) Changes of nutritional status according to Mini Nutritional Assessment questionnaire and metabolic profile according to biochemical analyses; 7) Rate of post-stroke complications, stroke -associated infections and re-hospitalization for any reason; 8) Safety and tolerability of EEAs supplementation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Physical examinations</head><p><s>Rivermead motor assessment (RMA) gross function scale comprised a series of 13 questions, and covers a range of activities from turning over in bed to hop on affected leg five times <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17]</ref>.</s><s>Hand grip strength <ref type="bibr" target="#b17">[18]</ref> and pinch grip tests measures muscle isometric strength.</s><s>The maximum value of three measurements will be evaluated <ref type="bibr" target="#b18">[19]</ref>.</s><s>Motor assessment scale (MAS) includes nine items scoring from 0 to 6, and is designed to assess eight areas</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1 Inclusion and exclusion criteria of the AMINO-Stroke</head><p><s>Inclusion criteria:</s></p><p><s>• Patient &gt;45 years</s></p><p><s>• Patients with ischemic or haemorrhagic stroke within 8 weeks to enrolment</s></p><p><s>• Brain magnet resonance imaging or computer tomography demonstrating stroke</s></p><p><s>• Motoric disability of an upper and /or lower limb (Rivermead Motor Assessment Gross Function &gt; 1 and &lt;11)</s></p><p><s>• Signed informed consent Exclusion criteria:</s></p><p><s>• Clinically significant findings on physical examination or presence of clinically significant disease that would interfere with study evaluation in the opinion of the treating physicians</s></p><p><s>• Participation in another clinical trial investigating a nutritional product</s></p><p><s>• History of intolerance or allergic response to similar nutritional products or known hypersensitivity to essential amino acids</s></p><p><s>• Clinical sighs and symptoms of infection requiring antibiotic therapy at the time of enrolment that prevent completion of trial-related assessments as judged by the investigator</s></p><p><s>• Transaminases (AST or ALT) &gt; 3 times the upper limit of normal (ULN)</s></p><p><s>• Severe renal dysfunction or nephrotic syndrome</s></p><p><s>• Acquired immunodeficiency syndrome, HIV or Hepatitis C infection</s></p><p><s>• Current therapy with anabolic steroids or appetite stimulants</s></p><p><s>• Current immunosuppressive therapy, heart transplantation, or renal dialysis</s></p><formula xml:id="formula_0">• Life expectancy &lt; 6 months</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 2 Functional assessment at baseline and during follow-up</head><p><s>Extended functional assessment at baseline and at 4 weeks follow-up</s></p><p><s>• Activity of daily living (modified Rankin scale, Barthel Index)</s></p><p><s>• Functional assessment scales and physical performance (Rivermead Motor Assessment Gross Function, Fugl-Meyer Scale, Functional ambulatory capacity)</s></p><p><s>• Muscle functional assessment (SPPBT, hand grip, pinch grip)</s></p><p><s>• Quality of life and nutritional status (EQ-5D, PGA)</s></p><p><s>• Blood and biomarker bank: metabolic /immunologic profile</s></p><p><s>• 24 h Holter electrocardiogram (ECG)</s></p><p><s>• Body composition by bioelectrical impendance analysis (BIA)</s></p><p><s>• Urine status Functional assessment at 3 and 6 months follow-up</s></p><p><s>• Activity of daily living (mRS, Barthel index)</s></p><p><s>• Muscle functional assessment (SPPBT, hand grip, pinch grip)</s></p><p><s>• Quality of life and nutritional status (EQ-5D, PGA)</s></p><p><s>• Blood and biomarker bank: metabolic/immunologic profile</s></p><p><s>• 24 h Holter ECG</s></p><p><s>• Body composition by bioelectrical impedance analysis (BIA)</s></p><p><s>• Urine status of motor function, balance, and muscle tone <ref type="bibr" target="#b19">[20]</ref>.</s><s>Fugl-Meyer scale is a system for the evaluation of motor function, balance, sensory qualities, and joint function in hemiplegic patients.</s><s>This system applies a cumulative numerical score <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b21">22]</ref>.</s><s>Functional Ambulation Category (FAC) includes six categories ranging from 0 to 5 and is defined by ability of the patient to ambulate, with a lowest score 0 for "patient cannot ambulate" to 5 "patient can ambulate independently" <ref type="bibr" target="#b22">[23]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Functional independency assessment</head><p><s>Barthel index (BI) will be used for the assessment of functional independence.</s><s>BI includes 10 basic aspects of activities related to self-care and mobility with scores of 0-100, where the lower scores indicate greater dependency <ref type="bibr" target="#b23">[24]</ref>.</s><s>Short physical performance battery test (SPPBT) includes examination of ability to stand with the feet together in the side-by-side, semi-tandem, and tandem positions, time to walk 3 or 4 meters, and time to rise from the chair and return to the seated position 5 times <ref type="bibr" target="#b24">[25]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Nutritional status and quality of life</head><p><s>Mini Nutritional Assessment (MNA) is a simple scale to measure nutritional status <ref type="bibr" target="#b25">[26]</ref>.</s><s>A score above 24 points identifies patients with a good nutritional status, whereas a score below 17 points reveals patients with malnutrition.</s><s>Subjective Global Assessment (SGA) assesses nutritional status based on features of the history and physical examination <ref type="bibr" target="#b26">[27]</ref>.</s><s>EQ-5D questionnaire is an instrument for the generic measurements of health-related quality of life, comprising a Visual Analogue Scale for self-rating of general health and five domains evaluating mobility, self-care, usual activities, pain/discomfort, and anxiety/depression <ref type="bibr" target="#b27">[28]</ref>.</s><s>A score of 1 is the best possible general health status in each case; the dimensions may also be expressed as percentage of patients scoring from 1 to 3 (best to worst health status) or percentage of patients with 'any' complaint (scoring 2 or 3 in each domain) <ref type="bibr" target="#b28">[29]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Body composition analysis</head><p><s>Body composition analysis at baseline and follow-up visits will be assessed by BIA device (BodyStat QuadScan 4000, Bodystat Limited, British Isles).</s><s>The BIA device measures resistance (R), reactance (Xc) and phase angle (φ).</s><s>The measurements will be performed in patients in supine position lying on a non-conducting surface with arms slightly abducted from the trunk and legs slightly separated, after resting at least for 20 min <ref type="bibr" target="#b29">[30]</ref>.</s><s>Surface electrodes will be placed on the dorsal surface of hand and foot of the similar side.</s><s>Skeletal muscle (SM) mass will be estimated according to the equation of Baumgartner at all <ref type="bibr" target="#b30">[31]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Serum biomarker assessment</head><p><s>Blood samples and urine status will be assessed at admission and discharge from the inpatient rehabilitation as well as at follow up visits for routine clinical parameters, inflammatory and metabolic markers, and safety analyses (liver and kidney function).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sample size calculation and statistical analyses</head><p><s>A total of 110 patients is planned to be enrolled in the study.</s><s>A prospective sample size calculation has been performed based on observational data from our study centre.</s><s>A sample size of 55 in each group will have 80 % power to detect a clinically relevant difference in Rivermead Motor Assessment Gross Function scale improvement between the groups of 1.5 points and a clinically relevant improvement of handgrip strength.</s><s>The analysis of primary endpoints will use the principle of intentionto-treat.</s><s>The carry-forward principle will be adopted for unavailable or missing data.</s><s>Treatment effect will be assessed by unpaired comparison of both treatment arms for the change from baseline using the Student t-test.</s><s>A significance level of α &lt; 0.05 will be specified to indicate statistical significance.</s><s>Secondary endpoints will be analyzed using standard statistical methods.</s><s>For safety endpoints Chi-squared test of Fisher's Exact test will be used for event rates (e.g., death, re-stroke, hospitalization, cardiovascular event)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The present AMINO Stroke study will be the first randomized double-blinded trial investigating an effect of essential amino acids (EAAs) on skeletal muscle functional capacity, muscle mass, muscle strength and physical performance in early post-stroke rehabilitation.</s><s>In addition, the effect of EAAs supplementation on strokerelated quality of life, nutritional status, activities of daily life and outcome will be evaluated.</s><s>An improvement of physical and functional performin stroke patients is expected after participating in 4-weeks rehabilitation program <ref type="bibr" target="#b31">[32]</ref>.</s><s>In the present study we expect a beneficial impact of the dietary supplementation of the EAA on skeletal muscle function and muscle mass during post-stroke rehabilitation.</s></p><p><s>The benefit of EAAs supplementation on skeletal muscle has been shown in several studies in elderly individuals.</s><s>Thus, an elevated level of muscle protein synthesis was dependent on the availability of EAAs in a dose-depended manner <ref type="bibr" target="#b32">[33]</ref>.</s><s>An experimental study performing in the young adults revealed an increase of leucine incorporation into the skeletal muscle proteins under administration of EEAs as a flooding dose <ref type="bibr" target="#b33">[34]</ref>.</s><s>Ingestion of EAAs shortly after exercise enhanced muscle protein synthesis in older adults, indicating a combination of EAAs with exercising as a sufficient therapy for the treatment of muscle wasting <ref type="bibr" target="#b34">[35]</ref>.</s><s>Another study showed an improvement of lean mass, muscle functional capacity and muscle strength after 16 weeks supplementation of EAAs and arginine in healthy elderly individuals <ref type="bibr" target="#b35">[36]</ref>.</s></p><p><s>A reduction of the muscle mass might be directly depending on a limited availability of the EEAs and other nutrients <ref type="bibr" target="#b13">[14]</ref>.</s><s>Impaired feeding which results in malnutrition is frequently observed in patients with dysphagia after stroke <ref type="bibr" target="#b36">[37]</ref>.</s><s>About 50 % of stroke patients have feeding difficulties due to dysphagia <ref type="bibr" target="#b37">[38]</ref>.</s><s>In older patients reduced nutritional status might be observed already at hospital admission with the diagnosis of acute stroke <ref type="bibr" target="#b38">[39]</ref>.</s><s>Patients with lower body weight have been observed to have worse fatal and non-fatal outcome after stroke <ref type="bibr" target="#b39">[40]</ref>.</s><s>While the inverse association of overweight and improved outcome has previously been termed obesity paradox <ref type="bibr" target="#b40">[41]</ref>, the perception advanced towards an obesity paradigm, acknowledging the protective overweight in cardiovascular disease <ref type="bibr" target="#b41">[42]</ref>.</s></p><p><s>Malnutrition and sarcopenia are often reported in the rehabilitation setting <ref type="bibr" target="#b42">[43,</ref><ref type="bibr" target="#b43">44]</ref>.</s><s>Therefore, we believe that supplementation of the EAAs will contribute to attenuation of muscle wasting and improve skeletal muscle recovery <ref type="bibr" target="#b44">[45]</ref>.</s><s>There are a number of methods available to assess muscle mass <ref type="bibr" target="#b45">[46]</ref>.</s><s>In the present study muscle mass will be estimated by using BIA that provides information to integrity of cell membrane and tissue interfaces, intracellular and extracellular fluid distribution, body fat and body lean mass <ref type="bibr" target="#b30">[31,</ref><ref type="bibr" target="#b46">47]</ref>.</s><s>Previously, a strong correlation between muscle mass assessed by BIA and magnetic resonance imaging has been shown <ref type="bibr" target="#b47">[48]</ref>.</s><s>The prevalence of sarcopenia using BIA measurements has been repeatedly examined in elderly <ref type="bibr" target="#b48">[49,</ref><ref type="bibr" target="#b49">50]</ref>, and in patients with neuromuscular or cerebrovascular disease <ref type="bibr" target="#b50">[51,</ref><ref type="bibr" target="#b51">52]</ref>.</s><s>Therefore we believe that BIA is an appropriate method for muscle mass assessment.</s></p><p><s>In Germany, stroke has not been selected for chronic disease management programs so far <ref type="bibr" target="#b52">[53]</ref>.</s><s>Post-stroke rehabilitation is usually recommended to start immediately following hospital discharge.</s><s>The so called early post-stroke rehabilitation phase includes about 4 weeks.</s><s>Mainly, recommendations given in discharge letters from acute care hospitals are frequently focusing on medical treatments <ref type="bibr" target="#b52">[53]</ref>.</s><s>At present, post-stroke management does not include monitoring of muscle mass, muscle strength and muscle function.</s><s>The European stroke guidelines do not consider post-stroke muscle wasting as a relevant complication <ref type="bibr" target="#b53">[54]</ref>.</s><s>However, recognition of this problem through the medical community might improve the long-term outcome after stroke.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc><div><p><s>Fig. 1 Overview of AMINO-Stroke study</s></p></div></figDesc></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We thank Mrs. Anja Kresse for the valuable assistance in the preparation and documentation of this study and Dr. Francesco S. Dioguardi for providing the EAAs supplementation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>The Center for Stroke Research Berlin (CSB) is an integrated research and treatment centre.</s><s>The AMINO Stroke Study receives funding from German Federal Ministry of Education and Research (BMBF; grant number BMBF 01EO1301).</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abbreviations</head><p><s>EEA: Essential amino acid; BI: Barthel Index; EQ-5D: Quality of life questionnaire; RMA: Rivermead motor assessment; MAS: Motor assessment scale; FAC: Functional ambulation category; SPPBT: Short physical performance battery test; MNA: Mini nutritional assessment; SGA: Subjective global assessment; BIA: Bioelectrical impedance analysis; SM: Skeletal muscle.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests</head><p><s>KGH reports lecture fees and study grants by Bayer Healthcare, lecture fees and a study grant by Sanofi, lecture fees and advisory board fees from Pfizer, lecture fees from Bristol-Myers Squibb as well as advisory board fees from Edwards Lifesciences.</s><s>Other authors report no competing interests.</s></p><p><s>Authors' contribution WD, UD and MJ intended this analysis and designed the study.</s><s>WD performed the statistical calculations.</s><s>NS wrote the manuscript.</s><s>NS, NE, AS, AM, KGH, SvH, SDA made substantial contributions to the study design.</s><s>NE initiated the registry of the trial.</s><s>All authors contributed relevant intellectual content to the manuscript and approved the final version.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Sarcopenia in stroke-facts and numbers on muscle loss accounting for disability after stroke</title>
		<author>
			<persName><forename type="first">N</forename><surname>Scherbakov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Doehner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cachexia Sarcopenia Muscle</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="5" to="8" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Stroke-related sarcopenia: specific characteristics</title>
		<author>
			<persName><forename type="first">N</forename><surname>Scherbakov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sandek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Doehner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Med Dir Assoc</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="272" to="276" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Longitudinal changes in muscle strength and mass after acute stroke</title>
		<author>
			<persName><forename type="first">Carin-Levy G</forename><surname>Greig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hannan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mead</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cerebrovasc Dis</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="201" to="207" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Changes in MM, fat mass, and bone mineral content in the legs after stroke: a 1 year prospective study</title>
		<author>
			<persName><forename type="first">L</forename><surname>Jørgensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Jacobsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="655" to="659" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Sarcopenia: origins and clinical relevance</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Rosenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="990S" to="991" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Physiopathological mechanism of sarcopenia</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Boirie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr Health Aging</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="717" to="723" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Stroke induced Sarcopenia: muscle wasting and disability after stroke</title>
		<author>
			<persName><forename type="first">N</forename><surname>Scherbakov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Von Haehling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Anker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Dirnagl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Doehner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="page" from="89" to="94" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Body weight after stroke: lessons from the obesity paradox</title>
		<author>
			<persName><forename type="first">N</forename><surname>Scherbakov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Dirnagl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Doehner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="3646" to="3650" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Catabolic signaling and muscle wasting after acute ischemic stroke in mice: indication for a stroke-specific sarcopenia</title>
		<author>
			<persName><forename type="first">J</forename><surname>Springer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schust</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Peske</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tschirner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rex</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="3675" to="3683" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Outcome and time course of recovery in stroke. Part II: Time course of recovery. The Copenhagen Stroke Study</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Jørgensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nakayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">O</forename><surname>Raaschou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vive-Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Støier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Olsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Phys Med Rehabil</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="406" to="412" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bamford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sandercock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dennis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Burn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Warlow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Neurosurg Psychiatry</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="16" to="22" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Effect of essential amino acid supplementation on quality of life, amino acid profile and strength in institutionalized elderly patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rondanelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Opizzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Antoniello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Boschi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Iadarola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pasini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="571" to="577" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled Trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Verlaan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Bautmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Brandt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Donini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maggio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Med Dir Assoc</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="740" to="747" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Clinical use of amino acids as dietary supplement: pros and cons</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Dioguardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cachexia Sarcopenia Muscle</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="75" to="80" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults</title>
		<author>
			<persName><forename type="first">E</forename><surname>Volpi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sheffield-Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mittendorfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Wolfe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="250" to="258" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Assessment of motor function in stroke patients</title>
		<author>
			<persName><forename type="first">N</forename><surname>Lincoln</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Leadbitter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiotherapy</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="48" to="51" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Collen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Wade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Robb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Bradshaw</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Disabil Stud</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="50" to="54" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Adequacy of hand-grip dynamometer for characterizing upper limb strength after stroke</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Bohannon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Isokinet Exerc Sci</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="263" to="265" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Reliability and validity of grip and pinch strength evaluations</title>
		<author>
			<persName><forename type="first">V</forename><surname>Mathiowetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Volland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kashman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hand Surg [Am]</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="222" to="226" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Investigation of a new motor assessment scale for stroke patients</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Carr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Shepherd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Nordholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lynne</forename><forename type="middle">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Phys Ther</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="175" to="180" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Fugl-Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jääskö</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Leyman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Olsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Steglind</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Rehabil Med</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="13" to="31" />
			<date type="published" when="1975">1975</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Fugl-Meyer assessment of sensorimotor function after stroke: standardized training procedure for clinical practice and clinical trials</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Tilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Cen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hershberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Correa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stroke</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="427" to="432" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Holden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Gill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Magliozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Piehl-Baker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Phys Ther</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="35" to="40" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Clinical interpretation and use of stroke scales</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Kasner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="603" to="612" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Guralnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Simonsick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ferrucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Glynn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Berkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Blazer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Gerontol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="M85" to="94" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Overview of the MNA-Its history and challenges</title>
		<author>
			<persName><forename type="first">B</forename><surname>Vellas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Villars</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Abellan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Soto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Rolland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guigoz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr Health Aging</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="456" to="465" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">What is subjective global assessment of nutritional status?</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Detsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mclaughlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Mendelson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JPEN J Parenter Enteral Nutr</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="8" to="13" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The development of new research methods for the valuation of EQ-5D-5 L</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Devlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Krabbe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Health Econ</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="S1" to="3" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Comin-Colet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lainscak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dickstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Filippatos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Lüscher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="30" to="38" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Assessment of fat-free mass using bioelectrical impedance measurements of the human body</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Lukaski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Bolonchuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Lykken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="810" to="817" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Bioelectric impedance phase angle and body composition</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Baumgartner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Chumlea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Roche</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="16" to="23" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Evaluation of C-terminal Agrin Fragment as a marker ofmuscle wasting in patients after acute stroke during early rehabilitation</title>
		<author>
			<persName><forename type="first">N</forename><surname>Scherbakov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Knops</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ebner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Valentova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sandek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Grittner</surname></persName>
		</author>
		<idno type="DOI">10.1002/jcsm.12068</idno>
	</analytic>
	<monogr>
		<title level="j">J Cachexia Sarcopenia Muscle</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle</title>
		<author>
			<persName><forename type="first">D</forename><surname>Cuthbertson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Babraj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Leese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Waddell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Atherton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="422" to="424" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Effects of flooding amino acids on incorporation of labeled amino acids into human muscle protein</title>
		<author>
			<persName><forename type="first">K</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Reynolds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Downie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Rennie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="E73" to="78" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Exercise, amino acids, and aging in the control of human muscle protein synthesis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Dickinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Timmerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Drummond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Reidy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Fry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Sci Sports Exerc</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="2249" to="2258" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Effect of amino acid supplementation on MM, strength and physical function in elderly</title>
		<author>
			<persName><forename type="first">E</forename><surname>Børsheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">U</forename><surname>Bui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tissier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Ferrando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Wolfe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="189" to="195" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">A review of the relationship between dysphagia and malnutrition following stroke</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Foley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Salter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Teasell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Rehabil Med</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="707" to="713" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Interventions for dysphagia and nutritional support in acute and subacute stroke</title>
		<author>
			<persName><forename type="first">C</forename><surname>Geeganage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Beavan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ellender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Bath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">D000323</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">The German hospital malnutrition study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Pirlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Schütz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Norman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gastell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Lübke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Bischoff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="563" to="572" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial</title>
		<author>
			<persName><forename type="first">W</forename><surname>Doehner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schenkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Anker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Springer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Audebert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="268" to="277" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">The obesity paradox in chronic disease: facts and numbers</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lainscak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Von Haehling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Doehner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Anker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cachexia Sarcopenia Muscle</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="1" to="4" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Protective overweight in cardiovascular disease: moving from &apos;paradox&apos; to &apos;paradigm&apos;</title>
		<author>
			<persName><forename type="first">W</forename><surname>Doehner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Von Haehling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Anker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>pubmed ahead of print</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management</title>
		<author>
			<persName><forename type="first">H</forename><surname>Wakabayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sakuma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cachexia Sarcopenia Muscle</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="269" to="277" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Sarcopenia: there is a need for some steps forward</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Michel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Med Dir Assoc</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="379" to="380" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Effectiveness of nutritional supplementation on muscle mass in treatment of sarcopenia in old age: a systematic review</title>
		<author>
			<persName><forename type="first">V</forename><surname>Malafarina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Uriz-Otano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Iniesta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gil-Guerrero</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Med Dir Assoc</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="10" to="17" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Assessing skeletal muscle mass: historical overview and state of the art</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Heymsfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Adamek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Gonzalez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Jia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Thomas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cachexia Sarcopenia Muscle</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="9" to="18" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">The bioimpedance phase angle predicts low muscle strength, impaired quality of life, and increased mortality in old patients with cancer</title>
		<author>
			<persName><forename type="first">K</forename><surname>Norman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wirth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Neubauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Eckardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Stobäus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Med Dir Assoc</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="173" to="e190" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Estimation of skeletal MM by bioelectrical impedance analysis</title>
		<author>
			<persName><forename type="first">I</forename><surname>Janssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Heymsfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Baumgartner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Appl Physiol</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="465" to="471" />
			<date type="published" when="1985">1985. 2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Low relative skeletal MM (sarcopenia) in older persons is associated with functional impairment and physical disability</title>
		<author>
			<persName><forename type="first">I</forename><surname>Janssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Heymsfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Geriatr Soc</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="889" to="896" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study</title>
		<author>
			<persName><forename type="first">D</forename><surname>Legrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vaes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Matheï</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Swine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Degryse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Age Ageing</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="727" to="734" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Localized bioimpedance analysis in the evaluation of neuromuscular disease</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Rutkove</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Aaron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Shiffman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="390" to="397" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Body composition assessed by anthropometry and bioelectric impedance analysis in older persons recovering from cerebrovascular accident</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sotillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>López-Jurado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Martín</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mataix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Llopis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Vitam Nutr Res</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="32" to="38" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPiRE-TMS): a protocol for a randomised controlled trial</title>
		<author>
			<persName><forename type="first">S</forename><surname>Leistner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Michelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Laumeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ahmadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Smyth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nieweler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Neurol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack</title>
	</analytic>
	<monogr>
		<title level="j">Cerebrovasc Dis</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="457" to="507" />
			<date type="published" when="2008">2008. 2008</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
